Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
INSM
#375
Insmed, Inc.
149.330
0
+1.83%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+1.83%
Aylık değişim
-7.17%
6 aylık değişim
-7.85%
Yıllık değişim
-7.85%
Önceki kapanış
146.640
0
Open
149.330
0
Bid
Ask
Low
149.330
0
High
149.330
0
Hacim
330
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
INSM
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
178.9 M
181 M
182.14 M
211.37 M
213.27 M
215.55 M
—
Valuation ratios
Enterprise value
12.6 B
11.94 B
13.49 B
19.99 B
30.38 B
37 B
100.86 B
Price to earnings ratio
-13.11
-12.39
-12.82
-17.69
-23.26
-27.11
-80.88
Price to sales ratio
32.79
31.14
33.58
44.63
60.27
57.12
195.59
Price to cash flow ratio
18.22
16.56
17.03
21.09
30.21
37.04
105.37
Price to book ratio
8.56
39.69
14.34
8.62
10.78
46.87
80.61
Enterprise value to EBITDA ratio
-96.64
-15.54
-24.84
-26.38
-31.32
-38.07
-120.6
Profitability ratios
Return on assets %
0.11
0.12
0.14
0.13
0.16
0.15
0.57
Return on equity %
0.46
0.83
2.59
0.26
0.39
0.44
3.68
Return on invested capital %
163.61
220.97
240.51
307.27
346.83
276.82
1 171.43
Gross margin %
77.34
74.96
77.08
73.86
79.37
83.24
313.55
Operating margin %
228.45
220.61
267.33
291.28
257.13
121.19
936.92
EBITDA margin %
-46.81
-230.45
-242.26
-231.3
-179.86
-92.01
-745.43
Net margin %
236.04
225.53
276.42
299.48
259.95
124.5
960.35
Liquidity ratios
Quick ratio
5.99
5.12
5.44
6.33
4.34
3.54
19.66
Current ratio
6.37
5.45
5.86
6.68
4.63
3.83
21
Inventory turnover
0.22
0.27
0.21
0.27
0.26
0.35
1.09
Asset turnover
0.05
0.05
0.05
0.05
0.06
0.11
0.27
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.47
0.54
0.61
0.22
0.23
0.24
1.3
Long term debt to total equity ratio
1.98
3.87
11.14
0.43
0.57
0.73
12.88
Per share metrics
Operating cash flow per share
1.04
1.19
1.45
1.09
1.04
1.24
4.82
EBIT per share
-0.28
-1.52
-1.27
-1.34
-1.24
-1.28
-5.14
EBITDA per share
-0.25
-1.47
-1.24
-1.31
-1.21
-1.22
-4.98
Total debt per share
—
—
—
—
—
—
—
Cash per share
8.45
8.74
6.63
9.81
7.93
7.19
31.56
Net current asset value per share
9.5
9.89
7.76
11
9.12
9.02
36.89
Tangible book value per share
1.65
0.55
-0.52
5.59
3.42
2.54
11.03
Working capital per share
8.01
8.07
6.43
9.35
7.15
6.66
29.59
Book value per share
2.78
1.74
0.55
6.6
4.47
3.71
15.33
Haberler
CEO da Insmed vende US$ 1,6 milhão em ações
Insmed chair and CEO Lewis sells $1.6m in stock
H.C. Wainwright reitera recomendação de compra para Insmed com preço-alvo de US$ 230
H.C. Wainwright reiterates Buy on Insmed stock, $230 target
Insmed Lags on Q4 Earnings, Stock Gains on 2026 Brinsupri Sales View
Insmed Incorporated 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:INSM) 2026-02-20
Insmed projeta crescimento de 139% na receita para 2026 com forte lançamento do BRINSUPRI
Insmed (INSM) Reports Q4 Loss, Lags Revenue Estimates
Lucro da Insmed veio abaixo das projeções por $0,37; receita supera estimativas
Insmed earnings missed by $0.37, revenue topped estimates
Walmart, Southern Co, Newmont Mining and more set to report earnings Thursday
Resultados da Insmed se aproximam: Brinsupri pode sustentar início de blockbuster?